Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 2

Sponsor Class

OTHER 2NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Sarcoma 1Lymphoid 1

Conditions

Leukemia, Myeloid, Acute 67Leukemia 28Precursor Cell Lymphoblastic Leukemia-Lymphoma 26Lymphoma 20Lymphoma, Follicular 14Congenital Abnormalities 14Lymphoma, Non-Hodgkin 13Recurrence 12Lymphoma, Large B-Cell, Diffuse 12Leukemia, Monocytic, Acute 12Myelodysplastic Syndromes 11Leukemia, Lymphocytic, Chronic, B-Cell 9Leukemia, Erythroblastic, Acute 9Prostatic Neoplasms 8Lymphoma, Large-Cell, Immunoblastic 8Leukemia, Myelomonocytic, Acute 8Leukemia, Megakaryoblastic, Acute 8Leukemia, Biphenotypic, Acute 8Lymphoma, Mantle-Cell 7Hodgkin Disease 5Burkitt Lymphoma 5Blast Crisis 5Lymphoma, B-Cell, Marginal Zone 3Leukemia, Promyelocytic, Acute 3Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3Sarcoma, Myeloid 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Ovarian Neoplasms 2Leukemia, Myelomonocytic, Chronic 2Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 2

Interventions

Cyclophosphamide 37fludarabine phosphate 32Peripheral Blood Stem Cell Transplantation 30Busulfan 28Tacrolimus 24Antilymphocyte Serum 23Mycophenolic Acid 21Filgrastim 21Radiotherapy 20Methotrexate 19Cyclosporine 19Melphalan 15Methylprednisolone 14Etoposide 14Whole-Body Irradiation 13Cord Blood Stem Cell Transplantation 11Therapeutics 9Psychiatric Rehabilitation 9Flow Cytometry 8sargramostim 7Sirolimus 7Cytarabine 7Alemtuzumab 6Polymerase Chain Reaction 5Granulocyte Colony-Stimulating Factor 5thymoglobulin 4aldesleukin 4Thiotepa 4Specimen Handling 4Early Intervention, Educational 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative × Mitoxantrone × Clear all
NCT00002598 2013-06-25

Combination Chemotherapy and Interferon Alfa in Treating Patients With Chronic Myelogenous Leukemia

Memorial Sloan Kettering Cancer Center

Phase 2 Completed
30 enrolled
Other hematologic neoplasm

Blast Crisis, Leukemia, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative

NCT00047021 2010-06-11

Combination Chemotherapy in Treating Patients With Recurrent or Refractory Leukemia or Lymphoma

Case Comprehensive Cancer Center

Phase 2 Completed
3 enrolled
LymphoidOther hematologic neoplasmSarcoma

Congenital Abnormalities, Blast Crisis, Burkitt Lymphoma, Hodgkin Disease, Leukemia, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Recurrence, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Acute, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative, Dendritic Cell Sarcoma, Interdigitating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡